(19)
(11) EP 2 609 431 A1

(12)

(43) Date of publication:
03.07.2013 Bulletin 2013/27

(21) Application number: 11754343.9

(22) Date of filing: 29.08.2011
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
(86) International application number:
PCT/EP2011/064839
(87) International publication number:
WO 2012/025636 (01.03.2012 Gazette 2012/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 11.01.2011 US 201161431515 P
11.01.2011 EP 11000146
27.08.2010 US 377663 P
27.08.2010 EP 10008937

(71) Applicant: University of Zurich
8006 Zurich (CH)

(72) Inventors:
  • BROKOPP, Chad
    8008 Zürich (CH)
  • HOERSTRUP, Simon
    8032 Zürich (CH)

(74) Representative: Steinecke, Peter 
Müller Fottner Steinecke Rechtsanwälte - Patentanwälte Postfach 11 40
52412 Jülich
52412 Jülich (DE)

   


(54) METHOD FOR TARGET AND DRUG VALIDATION IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES